A2001

Exempts drug manufacturers and distributors from pharmacist licensing for dialysis-related drugs and devices.

New Jersey A2001 exempts drug manufacturers and wholesale drug distributors from pharmacist licensing requirements for dialysate drugs and devices used in home dialysis for end-stage renal disease patients. This exemption applies if the drugs and devices are FDA-approved, held by a properly registered entity, delivered in original packaging, and distributed upon a physician's order. The bill also mandates periodic oversight by a licensed pharmacist.